M Ismail1, V Hill2, V Statsevych2, R Huang3, P Prasanna4, R Correa4, G Singh4, K Bera4, N Beig4, R Thawani4, A Madabhushi4, M Aahluwalia5, P Tiwari4. 1. From the Department of Biomedical Engineering (M.I., P.P., R.C., G.S., K.B., N.B., R.T., A.M., P.T.), Case Western Reserve University, Cleveland, Ohio mxi125@case.edu. 2. Department of Neuroradiology (V.H., V.S.), Imaging Institute. 3. Department of Radiology (R.H.), Brigham and Women's Hospital, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts. 4. From the Department of Biomedical Engineering (M.I., P.P., R.C., G.S., K.B., N.B., R.T., A.M., P.T.), Case Western Reserve University, Cleveland, Ohio. 5. Brain Tumor and Neuro-Oncology Center (M.A.), Cleveland Clinic, Cleveland, Ohio.
Abstract
BACKGROUND AND PURPOSE: Differentiating pseudoprogression, a radiation-induced treatment effect, from tumor progression on imaging is a substantial challenge in glioblastoma management. Unfortunately, guidelines set by the Response Assessment in Neuro-Oncology criteria are based solely on bidirectional diametric measurements of enhancement observed on T1WI and T2WI/FLAIR scans. We hypothesized that quantitative 3D shape features of the enhancing lesion on T1WI, and T2WI/FLAIR hyperintensities (together called the lesion habitat) can more comprehensively capture pathophysiologic differences across pseudoprogression and tumor recurrence, not appreciable on diametric measurements alone. MATERIALS AND METHODS: A total of 105 glioblastoma studies from 2 institutions were analyzed, consisting of a training (n = 59) and an independent test (n = 46) cohort. For every study, expert delineation of the lesion habitat (T1WI enhancing lesion and T2WI/FLAIR hyperintense perilesional region) was obtained, followed by extraction of 30 shape features capturing 14 "global" contour characteristics and 16 "local" curvature measures for every habitat region. Feature selection was used to identify most discriminative features on the training cohort, which were evaluated on the test cohort using a support vector machine classifier. RESULTS: The top 2 most discriminative features were identified as local features capturing total curvature of the enhancing lesion and curvedness of the T2WI/FLAIR hyperintense perilesional region. Using top features from the training cohort (training accuracy = 91.5%), we obtained an accuracy of 90.2% on the test set in distinguishing pseudoprogression from tumor progression. CONCLUSIONS: Our preliminary results suggest that 3D shape attributes from the lesion habitat can differentially express across pseudoprogression and tumor progression and could be used to distinguish these radiographically similar pathologies.
BACKGROUND AND PURPOSE: Differentiating pseudoprogression, a radiation-induced treatment effect, from tumor progression on imaging is a substantial challenge in glioblastoma management. Unfortunately, guidelines set by the Response Assessment in Neuro-Oncology criteria are based solely on bidirectional diametric measurements of enhancement observed on T1WI and T2WI/FLAIR scans. We hypothesized that quantitative 3D shape features of the enhancing lesion on T1WI, and T2WI/FLAIR hyperintensities (together called the lesion habitat) can more comprehensively capture pathophysiologic differences across pseudoprogression and tumor recurrence, not appreciable on diametric measurements alone. MATERIALS AND METHODS: A total of 105 glioblastoma studies from 2 institutions were analyzed, consisting of a training (n = 59) and an independent test (n = 46) cohort. For every study, expert delineation of the lesion habitat (T1WI enhancing lesion and T2WI/FLAIR hyperintense perilesional region) was obtained, followed by extraction of 30 shape features capturing 14 "global" contour characteristics and 16 "local" curvature measures for every habitat region. Feature selection was used to identify most discriminative features on the training cohort, which were evaluated on the test cohort using a support vector machine classifier. RESULTS: The top 2 most discriminative features were identified as local features capturing total curvature of the enhancing lesion and curvedness of the T2WI/FLAIR hyperintense perilesional region. Using top features from the training cohort (training accuracy = 91.5%), we obtained an accuracy of 90.2% on the test set in distinguishing pseudoprogression from tumor progression. CONCLUSIONS: Our preliminary results suggest that 3D shape attributes from the lesion habitat can differentially express across pseudoprogression and tumor progression and could be used to distinguish these radiographically similar pathologies.
Authors: P Tiwari; P Prasanna; L Wolansky; M Pinho; M Cohen; A P Nayate; A Gupta; G Singh; K J Hatanpaa; A Sloan; L Rogers; A Madabhushi Journal: AJNR Am J Neuroradiol Date: 2016-09-15 Impact factor: 3.825
Authors: Philipp Kickingereder; Sina Burth; Antje Wick; Michael Götz; Oliver Eidel; Heinz-Peter Schlemmer; Klaus H Maier-Hein; Wolfgang Wick; Martin Bendszus; Alexander Radbruch; David Bonekamp Journal: Radiology Date: 2016-06-20 Impact factor: 11.105
Authors: Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee Journal: IEEE Trans Med Imaging Date: 2010-04-08 Impact factor: 10.048
Authors: Evangelia I Zacharaki; Sumei Wang; Sanjeev Chawla; Dong Soo Yoo; Ronald Wolf; Elias R Melhem; Christos Davatzikos Journal: Magn Reson Med Date: 2009-12 Impact factor: 4.668
Authors: Niha Beig; Kaustav Bera; Prateek Prasanna; Jacob Antunes; Ramon Correa; Salendra Singh; Anas Saeed Bamashmos; Marwa Ismail; Nathaniel Braman; Ruchika Verma; Virginia B Hill; Volodymyr Statsevych; Manmeet S Ahluwalia; Vinay Varadan; Anant Madabhushi; Pallavi Tiwari Journal: Clin Cancer Res Date: 2020-02-20 Impact factor: 12.531
Authors: Charlems Alvarez-Jimenez; Jacob T Antunes; Nitya Talasila; Kaustav Bera; Justin T Brady; Jayakrishna Gollamudi; Eric Marderstein; Matthew F Kalady; Andrei Purysko; Joseph E Willis; Sharon Stein; Kenneth Friedman; Rajmohan Paspulati; Conor P Delaney; Eduardo Romero; Anant Madabhushi; Satish E Viswanath Journal: Cancers (Basel) Date: 2020-07-24 Impact factor: 6.639
Authors: Seung Won Choi; Hwan-Ho Cho; Harim Koo; Kyung Rae Cho; Karl-Heinz Nenning; Georg Langs; Julia Furtner; Bernhard Baumann; Adelheid Woehrer; Hee Jin Cho; Jason K Sa; Doo-Sik Kong; Ho Jun Seol; Jung-Il Lee; Do-Hyun Nam; Hyunjin Park Journal: Cancers (Basel) Date: 2020-06-27 Impact factor: 6.639